Free photo 1612846 © Lemonpink – Dreamstime.com
HARTFORD, CT – Governor Ned Lamont on Sunday announced that the Connecticut COVID-19 Vaccine Advisory Group’s Science Subcommittee has submitted recommendations to him that the state’s COVID-19 vaccine distribution plan start at the earliest opportunity. The recommendation comes after the subcommittee reviewed all available scientific and trial data from the U.S. Food and Drug Administration (FDA), the FDA’s Vaccine and Related Biological Products Advisory Committee, clinical trial information provided by Pfizer and BioNTech, and peer-reviewed scientific publications about the vaccine and its clinical testing. The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) also voted to recommend the vaccine for individuals over 16.
Governor Lamont Announces Connecticut Vaccine Distribution Plan To Begin
hamlethub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hamlethub.com Daily Mail and Mail on Sunday newspapers.
Connecticut Vaccine Distribution Plan To Begin
hamlethub.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hamlethub.com Daily Mail and Mail on Sunday newspapers.
UpdatedSun, Dec 13, 2020 at 1:35 pm ET
Replies(59)
On Sunday, Gov. Ned Lamont announced that the Connecticut COVID-19 Vaccine Advisory Group’s Science Subcommittee has submitted recommendations to him that the state’s COVID-19 vaccine distribution plan start at the earliest opportunity. (Shutterstock)
CONNECTICUT On Sunday, Gov. Ned Lamont announced that the Connecticut COVID-19 Vaccine Advisory Group s Science Subcommittee has submitted recommendations to him that the state s COVID-19 vaccine distribution plan start at the earliest opportunity.
The recommendation comes after the subcommittee reviewed all available scientific and trial data from the U.S. Food and Drug Administration (FDA), the FDA s Vaccine and Related Biological Products Advisory Committee, clinical trial information provided by Pfizer and BioNTech, and peer-reviewed scientific publications about the vaccine and its clinical testing, Lamont said in a news release.